
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; 2 Department of Medical Epidemiology and Biostatistics and 3 Department of Pathology and Oncology, Karolinska Institutet; 4 Department of Pathology, Karolinska University Hospital, Stockholm, Sweden; 5 Department of Medicine, Vejle Hospital, Vejle, Denmark; 6 Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden; and 7 Department of Oncology, Radiology, and Clinical Immunology, Uppsala University, Uppsala, Sweden
Requests for reprints: Claudia Schöllkopf, Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark; Phone: 45-3268-3222; Fax: 45-3268-3165. E-mail: CKO{at}SSI.dk
Background: Epidemiologic evidence of an association between tobacco smoking and non-Hodgkin's lymphoma has been conflicting. This may reflect that non-Hodgkin's lymphoma comprises several distinct disease entities with different etiologies, as some studies have indicated an association between smoking and follicular lymphoma.
Objective: To investigate the association between cigarette smoking and non-Hodgkin's lymphoma risk, overall and by subtype.
Methods: As part of a nationwide Danish-Swedish population-based case-control study, we interviewed 3,055 incident non-Hodgkin's lymphoma patients and 3,187 population controls. All lymphomas were uniformly classified according to the WHO classification. We used unconditional logistic regression to estimate adjusted odds ratios (OR) and 95% confidence intervals (95% CI) for the association between cigarette smoking and risk of non-Hodgkin's lymphoma.
Results: Cigarette smoking was not associated with the risk of non-Hodgkin's lymphoma overall (OR, 0.97; 95% CI, 0.87-1.08) nor with the major subgroups such as diffuse large B-cell lymphoma (OR, 0.94; 95% CI, 0.79-1.10), chronic lymphocytic leukemia (OR, 0.86; 95% CI, 0.72-1.02), or follicular lymphoma (OR, 1.03; 95% CI, 0.85-1.24). Female smokers were at a marginally increased risk of follicular lymphoma (OR, 1.41; 95% CI, 1.04-1.92). Men who had ever smoked had a significantly increased risk of T-cell lymphoma (OR, 1.67; 95% CI, 1.11-2.51). No dose-response association with cigarette smoking could be established for any lymphoma subgroup.
Conclusion: We found little evidence of an association between cigarette smoking and non-Hodgkin's lymphoma risk overall. Although increased risks of follicular lymphoma in female smokers and of T-cell lymphoma in male smokers were suggested, no dose-response relationship was observed, leaving limited support for causality.
This article has been cited by other articles:
![]() |
B. C.-H. Chiu, Q. Lan, B. J. Dave, A. Blair, S. H. Zahm, and D. D. Weisenburger The Utility of t(14;18) in Understanding Risk Factors for Non-Hodgkin Lymphoma J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 69 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nieters, S. Rohrmann, N. Becker, J. Linseisen, T. Ruediger, K. Overvad, A. Tjonneland, A. Olsen, N. E. Allen, R. C. Travis, et al. Smoking and Lymphoma Risk in the European Prospective Investigation into Cancer and Nutrition Am. J. Epidemiol., May 1, 2008; 167(9): 1081 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hjalgrim, K. Ekstrom-Smedby, K. Rostgaard, R.-M. Amini, D. Molin, S. Hamilton-Dutoit, C. Schollkopf, E. T. Chang, E. Ralfkiaer, H.-O. Adami, et al. Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Chang, K. M. Balter, A. Torrang, K. E. Smedby, M. Melbye, C. Sundstrom, B. Glimelius, and H.-O. Adami Nutrient Intake and Risk of Non-Hodgkin's Lymphoma Am. J. Epidemiol., December 15, 2006; 164(12): 1222 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ekstrom Smedby, C. M. Lindgren, H. Hjalgrim, K. Humphreys, C. Schollkopf, E. T. Chang, G. Roos, L. P. Ryder, K. I. Falk, J. Palmgren, et al. Variation in DNA Repair Genes ERCC2, XRCC1, and XRCC3 and Risk of Follicular Lymphoma. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 258 - 265. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |